...
首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats.
【24h】

Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats.

机译:青年自发性高血压大鼠肾脏和血管中一氧化氮合酶的上调。

获取原文
获取原文并翻译 | 示例
           

摘要

The available data on the role of the L-arginineitric oxide (NO) pathway in the genesis of hypertension in spontaneously hypertensive rats (SHR) are limited and contradictory. In an attempt to address this issue, male SHR were studied during the early phase of evolution of hypertension (age 8 to 12 weeks) to distinguish the primary changes of NO metabolism from those caused by advanced hypertension, vasculopathy, and aging late in the course of the disease. A group of age-matched male Wistar-Kyoto rats (WKY) served as controls. The SHR exhibited a marked rise in arterial blood pressure and a significant increase in urinary excretion and plasma concentration of NO metabolites (nitriteitrate [NOx]). Likewise, the SHR showed a significant elevation of thoracic aorta NO synthase (NOS) activity coupled with significant increases of kidney, aorta, inducible NOS (iNOS), and endothelial NOS (eNOS) proteins. In an attempt to determine whether the enhanced L-arginine/NO pathway is a consequence of hypertension, studies were repeated using 3-week-old animals before the onset of hypertension. The study revealed significant increases in urinary NOx excretion as well as vascular eNOS and renal iNOS proteins. In conclusion, the L-arginine/NO pathway is upregulated in young SHR both before and after the onset of hypertension. Thus, development of hypertension is not due to a primary impairment of NO production in SHR. On the contrary, NO production is increased in young SHR both before and after the onset of hypertension.
机译:关于L-精氨酸/一氧化氮(NO)途径在自发性高血压(SHR)高血压发生中的作用的可用数据有限且相互矛盾。为了解决这个问题,在高血压发展的早期阶段(8至12周)对男性SHR进行了研究,以将NO代谢的主要变化与晚期高血压,血管病变和衰老后期引起的NO代谢区别开来。这种疾病。一组年龄匹配的雄性Wistar-Kyoto大鼠(WKY)作为对照。 SHR表现出明显的动脉血压升高,尿中排泄物和NO代谢物(亚硝酸盐/硝酸盐[NOx])的血浆浓度显着增加。同样,SHR显示胸主动脉NO合酶(NOS)活性显着升高,同时肾脏,主动脉,诱导型NOS(iNOS)和内皮NOS(eNOS)蛋白显着增加。为了确定增强的L-精氨酸/ NO途径是否是高血压的结果,在高血压发作之前对3周龄的动物进行了重复研究。该研究表明,尿中NOx排泄以及血管eNOS和肾脏iNOS蛋白显着增加。总之,年轻SHR在高血压发作之前和之后,L-精氨酸/ NO途径均被上调。因此,高血压的发生不是由于SHR中NO生成的主要损害。相反,年轻的SHR在高血压发作之前和之后均未产生NO。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号